One-Year Mortality of Patients After Emergency Department Treatment for Nonfatal Opioid Overdose.


Journal

Annals of emergency medicine
ISSN: 1097-6760
Titre abrégé: Ann Emerg Med
Pays: United States
ID NLM: 8002646

Informations de publication

Date de publication:
01 2020
Historique:
received: 19 12 2018
revised: 10 04 2019
accepted: 18 04 2019
pubmed: 24 6 2019
medline: 25 4 2020
entrez: 24 6 2019
Statut: ppublish

Résumé

Despite the increased availability of naloxone, death rates from opioid overdose continue to increase. The goal of this study is to determine the 1-year mortality of patients who were treated for a nonfatal opioid overdose in Massachusetts emergency departments (EDs). This was a retrospective observational study of patients from 3 linked statewide Massachusetts data sets: a master demographics list, an acute care hospital case-mix database, and death records. Patients discharged from the ED with a final diagnosis of opioid overdose were included. The primary outcome measure was death from any cause within 1 year of overdose treatment. During the study period, 17,241 patients were treated for opioid overdose. Of the 11,557 patients who met study criteria, 635 (5.5%) died within 1 year, 130 (1.1%) died within 1 month, and 29 (0.25%) died within 2 days. Of the 635 deaths at 1 year, 130 (20.5%) occurred within 1 month and 29 (4.6%) occurred within 2 days. The short-term and 1-year mortality of patients treated in the ED for nonfatal opioid overdose is high. The first month, and particularly the first 2 days after overdose, is the highest-risk period. Patients who survive opioid overdose should be considered high risk and receive interventions such as being offered buprenorphine, counseling, and referral to treatment before ED discharge.

Identifiants

pubmed: 31229387
pii: S0196-0644(19)30343-9
doi: 10.1016/j.annemergmed.2019.04.020
pmc: PMC6920606
mid: NIHMS1527784
pii:
doi:

Substances chimiques

Analgesics, Opioid 0

Types de publication

Journal Article Multicenter Study Observational Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-17

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA044167
Pays : United States

Informations de copyright

Copyright © 2019 American College of Emergency Physicians. Published by Elsevier Inc. All rights reserved.

Références

JAMA. 2015 Apr 28;313(16):1636-44
pubmed: 25919527
MMWR Morb Mortal Wkly Rep. 2018 Mar 09;67(9):279-285
pubmed: 29518069
MMWR Morb Mortal Wkly Rep. 2018 Mar 30;67(12):349-358
pubmed: 29596405

Auteurs

Scott G Weiner (SG)

Brigham and Women's Hospital, Boston, MA. Electronic address: sweiner@bwh.harvard.edu.

Olesya Baker (O)

Brigham and Women's Hospital, Boston, MA.

Dana Bernson (D)

Massachusetts Department of Public Health, Boston, MA.

Jeremiah D Schuur (JD)

Alpert Medical School, Brown University, Providence, RI.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH